Siemens Healthineers AG
Company Snapshot
Company Overview
Siemens Healthineers develops and manufactures diagnostic and therapeutic products to healthcare providers in more than 180 countries. It also provides clinical consulting services. As of Sept. 30, 2023, the Siemens Group held just over 75% of the shares in Siemens Healthineers AG.
Its business operations are divided into four segments: Imaging, Diagnostics, Varian and Advanced Therapies. The Cancer Therapy business (imaging for radiation therapy) was assigned to the Varian segment on Oct. 1, 2022. Siemens acquired Varian Medical Systems Inc. in 2021. Varian’s Radiation Oncology Solutions business serves the end-to-end needs of customers with integrated equipment and digital solutions.
The portfolio of its Diagnostics segment comprises in-vitro diagnostic products and services that it offers to healthcare providers in the fields of laboratory diagnostics and point-of-care diagnostics.
Financial Highlights (FY 2024)
This information is available for BCC Research members only.
Company's Business Segments
- Imaging : Devices for magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound.
- Diagnostics : Testing disciplines, including immunochemistry, hematology, coagulation, urinalysis, blood gas analysis, and molecular tests.
- Varian : Multi-modality cancer care technologies based on integrated, advanced imaging, along with solutions and services to oncology departments, integrated equipment and digital solutions.
- Advanced Therapies : Angiography systems and mobile C-arms.
Applications/End User Industries
- Theranostics
- Cardiology
- Neurology
- Oncology
- Surgery
- Interventional Radiology
- Hepatology
- Critical Care
- Covid-19
- Women's Health
- Medical Devices
- Healthcare
- Assays by diseases & conditions
